Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2006
03/22/2006EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/22/2006CN1751101A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
03/22/2006CN1751053A Salts comprising cyanoborate anions
03/22/2006CN1751039A Pyridine derivatives as fungicidal compounds
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/22/2006CN1751026A Novel crystalline modification of the anhydrate of boscalid
03/22/2006CN1751025A Diamine derivatives
03/22/2006CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
03/22/2006CN1749249A Chiral ionic liquid and its preparing method
03/22/2006CN1246341C Polymerization catalysts
03/22/2006CN1246319C Amino (thio) ether derivative
03/22/2006CN1246313C New method for preparing 3-pyridine acetic hydrochloride
03/22/2006CN1245939C Non-spherical and non-platelet pyrithione salts
03/22/2006CN1245938C Novel dyeing composition for dyeing-keratinous fibers comprising particular dicationic diazo dye
03/21/2006US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
03/21/2006US7015329 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/21/2006US7015237 Pyridine matrix metalloproteinase inhibitors
03/21/2006US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
03/21/2006US7015208 carbocyclic alcohols such as 5-Chloro-2-methylsulfonylindan-1-ol and isomers, used as anorexigenic agents; side effect reduction; nontoxic
03/21/2006CA2315220C Integrin receptor antagonists
03/21/2006CA2263983C Cyclic amine derivatives for inhibiting blood platelet aggregation
03/21/2006CA2261305C Combinatorial synthesis and analysis of organometallic compounds and catalysts
03/21/2006CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
03/21/2006CA2139112C Novel nicotinic acid esters
03/21/2006CA2072416C Cyclopropenone derivatives
03/16/2006WO2006028958A2 Pyridyl inhibitors of hedgehog signalling
03/16/2006WO2006027348A1 Phenylaminopyridines
03/16/2006WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors
03/16/2006WO2005123680B1 Six-membered heterocycles useful as serine protease inhibitors
03/16/2006WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
03/16/2006WO2005103003A3 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
03/16/2006WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators
03/16/2006US20060058570 Radioactive member and method of making
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058529 in high yield from a readily available material through a short process under mild reaction conditions using a reagent which is easy for handling and simple in the reaction operation
03/16/2006US20060058526 Reacting compounds such as ethyl 3-oxo-3-pyridin-4-yl propanoate with fluorine gas in the presence of one or more acid to produce pyridinyl or pyrimidinyl mono-fluorinated beta keto esters
03/16/2006US20060058396 Amide compounds for the potentiation of cholinergic activity
03/16/2006US20060058380 Novel aminobenzophenone compounds
03/16/2006US20060058359 Compounds useful as pesticides
03/16/2006US20060058357 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
03/16/2006US20060058354 Conjugated aromatic compounds with a pyridine substituent
03/16/2006US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/16/2006US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060058294 Carboxamidine derivatives and their use in the treatment of vascular diseases
03/16/2006US20060058259 Human t-cell,lymphocyte virus; hepatitis virus
03/16/2006US20060058178 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions
03/16/2006US20060057481 good charge transporting capability, good electric sensitivity and light responsibility, good electric and mechanical durability and good environment stability
03/16/2006CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
03/16/2006CA2579004A1 Mercaptoamides as histone deacetylase inhibitors
03/16/2006CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
03/15/2006EP1634867A1 Tricyanomethane salts of organic cations
03/15/2006EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
03/15/2006EP1633715A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
03/15/2006EP1633714A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
03/15/2006EP1633713A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
03/15/2006EP1633712A2 Six membered amino-amide derivatives as angiogenesis inhibitors
03/15/2006EP1633694A2 Substituted indoles and a process for preparing substituted indoles
03/15/2006EP1633354A2 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes
03/15/2006EP1633310A2 Thiotungstate analogues and uses thereof
03/15/2006EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/15/2006EP1408962B1 Substituted isoindoles and the use thereof
03/15/2006EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups
03/15/2006EP1309589B1 Urea compounds and methods of uses
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1747933A New mono-acylated o-phenylendiamines derivatives
03/15/2006CN1747932A Process for preparing pyridine-substituted amino ketal derivatives
03/15/2006CN1747926A Substituted amides
03/15/2006CN1245401C 6-aryl-4-aminopicolinates and their use as herbicides
03/15/2006CN1245394C Substituted phenylacetamides and their use as glucokinase activators
03/15/2006CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof
03/15/2006CN1245384C Carboxamides as fungicides in agriculture
03/15/2006CN1245381C Phenylglycine derivatives
03/15/2006CN1245380C Anthranilic acid derivatives
03/15/2006CN1245162C Synergistic precursor medicine compound for treating Alzheimer disease
03/14/2006US7012165 Oxidative fluorination of aromatic and chloroaromatic derivatives
03/14/2006US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
03/14/2006US7012141 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor nad acceptor dyes linked together
03/14/2006US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis
03/14/2006US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders
03/14/2006US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
03/14/2006US7012077 Anticholesterol agents; antilipemic agents
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2308867C New substitute pyridine or piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds
03/14/2006CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/14/2006CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/14/2006CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors
03/09/2006WO2006025979A2 Modulators of nuclear receptors
03/09/2006WO2006024523A1 Phthalamide derivatives for use as insecticides
03/09/2006WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
03/09/2006WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006WO2005058841A3 Hiv protease inhibiting compounds
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands